Added to YB: 2024-10-31
Pitch date: 2024-09-30
207940.KS [bullish]
Samsung Biologics Co.,Ltd.
+27.52%
current return
Author Info
No bio for this author
Company Info
Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
Market Cap
KRW 70.1T
Pitch Price
KRW 1.2M
Price Target
N/A
Dividend
N/A
EV/EBITDA
24.81
P/E
57.89
EV/Sales
14.46
Sector
Life Sciences Tools and Services
Category
growth
Artisan Sustainable Emerging Markets Fund Portfolio Holding: Samsung Biologics Co.,Ltd.
207940.KS: Samsung Biologics up on 2 FDA approvals. Strong partnerships with top pharma cos. Secured large-scale manufacturing deals. Well-positioned for biopharma market growth. Korean leader gaining momentum in global market.
Read full article (1 min)